All News
#ACR 2024 BEST Abstracts from Day 2
Here’s a collection of some of the best abstracts presented on day 2 of ACR 2024 as selected by the RheumNow faculty.
Read Article
Shedding Weight and Pain: The Promise of Anti-Obesity Medications in RA
With the advent of FDA-approved anti-obesity medications such as semaglutide and tirzepatide, a new avenue for managing this challenging patient population has emerged. But how might these drugs impact the trajectory of RA, and are we on the cusp of a paradigm shift?
Read ArticleWhere there’s smoke, there’s flare: how pollution fuels RA
Associations between air pollution and disease activity in rheumatoid arthritis have previously been demonstrated. Abstract 0978 sought to determine the association between fire smoke and other pollutant exposures with the risk of RA and RA-associated interstitial lung disease (RA-ILD).
Read Article
Richard Conway RichardPAConway ( View Tweet)
Richard Conway RichardPAConway ( View Tweet)
Richard Conway RichardPAConway ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)
Janet Pope Janetbirdope ( View Tweet)
Mrinalini Dey DrMiniDey ( View Tweet)
Mrinalini Dey DrMiniDey ( View Tweet)
Links:


